Alafair Biosciences Inc, a commercial-stage medical device company, has launched its VersaWrap, a bioresorbable hydrogel implant that provides a gelatinous, non-constricting interface between tendons and/or peripheral nerves and surrounding tissues, it was reported on Thursday.

The product is a hydrogel implant device indicated for the management of tendon and/or peripheral nerve tissues. It is an ultrathin, sutureless, semi-permeable, hyaluronic-acid rich layer that encases injured or exposed tendon and/or peripheral nerves.

Robert Slater, MD, FACS an orthopaedic surgeon in Sacramento, California, who is a clinical professor of Orthopaedics at UC-Davis and a leader of several professional organisations, said, 'VersaWrap is unique. As a bioresorbable, conformable hydrogel, VersaWrap's hydrophilic surface improves gliding of not just tendons but nearby tissues such as peripheral nerve. Unlike collagen-based products, VersaWrap is ultrathin and gelatinous, making it easier to use in the delicate, confined areas of the hand and wrist that are most often injured and in need of protection. My VersaWrap patients tend to have less post-operative inflammation and swelling and have a more pliable soft tissue envelope around the repair, which often allows them to return to full function more quickly and with less pain.'